Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Arch Dis Child Fetal Neonatal Ed ; 97(2): F106-9, 2012 Mar.
Article in English | MEDLINE | ID: mdl-21659622

ABSTRACT

OBJECTIVE: To evaluate the prognostic value of EEG regarding the psychomotor outcomes of very premature newborns. METHODS: 76 premature infants <30 weeks gestation were enrolled between January 2001 and August 2004. They were examined at 4 and 9 months corrected ages, and at 18 months, 3-4 years and 5-6 years. EEGs performed in the neonatal period were analysed by two neurologists blind to the child's outcome. RESULTS: The mean follow-up was 5.6 years. 25 infants had normal neurological development and all EEGs were normal for 22 of these. 36 others had developmental disabilities (7 motor sequelae and 29 delayed psychomotor development). Of 187 EEGs, 43 were dysmature, 13 disorganised, 2 displayed electrical seizures without clinical manifestations and 15 showed other abnormal features. Dysmaturity was the predominant EEG pattern in newborns with severe or moderate sequelae and was persistent on several EEGs in 12 of these. In contrast, only three infants with normal development had a dysmature pattern on one EEG. All infants with a disorganised pattern had cognitive sequelae, and two had cerebral palsy. The sensitivity of EEG regarding psychomotor outcome was 83.3%, the specificity was 88% and the positive predictive value was 90.9%. CONCLUSIONS: Very preterm neonates remain at high risk of neurological sequelae and EEG is a sensitive method for assessing neuromotor and cognitive prognosis. A dysmature pattern was the predominant EEG characteristic in infants who developed severe or moderate impairment. Early postnatal tracing is useful but additional recordings are generally necessary to detect high-risk newborns.


Subject(s)
Developmental Disabilities/diagnosis , Electroencephalography/methods , Infant, Low Birth Weight/physiology , Infant, Premature/physiology , Birth Weight , Cognition Disorders/diagnosis , Cognition Disorders/etiology , Developmental Disabilities/etiology , Female , Follow-Up Studies , Gestational Age , Humans , Infant, Newborn , Male , Prognosis , Psychomotor Disorders/diagnosis , Psychomotor Disorders/etiology , Psychomotor Performance , Retrospective Studies
2.
J Inherit Metab Dis ; 30(4): 613, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17632692

ABSTRACT

Newborn screening (NBS) of cystic fibrosis (CF) was implemented throughout the whole of France in 2002, but it had been established earlier in three western French regions. It can reveal atypical CF with one or two known CFTR mild mutations, with an uncertain evolution. The sweat test can be normal or borderline. In Brittany, from 1989 to 2004, 196 CF cases were diagnosed (1/2885 births). The incidence of atypical CF diagnosed by NBS is 9.7% (19 from 196). The outcome of 17 (2 lost of view) has been studied, with 9 other atypical CF cases diagnosed by NBS in two other regions. The follow-up period extends from 0.25 to 19.8 years (NBS implemented in Normandy in 1980) with mean age 4.6 years. The most frequent mild mutation is R117H ISV8-7T (50%). At the time of the last visit, nutritional status is normal. All these CF patients are pancreatic sufficient. Only one patient exhibits respiratory infections, whereas 7 others have them intermittently. Two of them had intermittent Pseudomonas aeruginosa colonization at 2.8 and 6.5 years. Mean Shwachman score is 96.7, mean Brasfield score is 22.8. Eight children have had lung function tests (mean follow-up of 10 years): mean FVC was 99% of predicted, mean FEV1 101%, but one of them has FEV1 of 48%. Predicting the phenotype of these atypical CF patients remains difficult, thus complicating any genetic counselling. A regular clinical evaluation is necessary, if possible by a CF unit, because CF symptoms may appear later.


Subject(s)
Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Cystic Fibrosis/blood , Cystic Fibrosis/diagnosis , Cystic Fibrosis/genetics , Mutation , Neonatal Screening/methods , Adolescent , Child , Child, Preschool , Cystic Fibrosis/complications , Female , Humans , Infant , Infant, Newborn , Male , Predictive Value of Tests , Pseudomonas Infections/complications , Reproducibility of Results
SELECTION OF CITATIONS
SEARCH DETAIL
...